We’re experiencing issues with our datasets and search. We apologise for any inconvenience while we work to fix this.
What's new
This page lists items that we have published for the first time or updated in the last 7, 30 or 60 days. Use the filters to narrow results by audience, product type, content type or topic.
You can also stay informed by:
- subscribing to our updates to receive same-day notification emails on safety information, scheduling updates or media releases.
- checking our consultation hub.
- joining any upcoming events.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advertising (4)
- Clinical trials (1)
- Committees and advisory bodies (3)
- Compliance and enforcement (8)
- COVID-19 (2)
- Fees and payments (3)
- Import and export (4)
- Labelling and packaging (6)
- Manufacturing (5)
- Medicinal cannabis hub (4)
- Safety monitoring and information (10)
- Scheduling (national classification system) (5)
- Shortages and supply disruptions (7)
- Sunscreens (2)
- Unique Device Identification (UDI) hub (10)
- Vaping hub (1)
- Weight loss products (2)
What's new
91 result(s) found, displaying 1 to 25
-
ConsultationWe are seeking feedback on the regulation of radiopharmaceuticals in Australia. These medicines contain small amounts of radioactive material, used to support the diagnosis and treatment of serious conditions, including cancer and cardiovascular disease.
-
ConsultationWe are seeking feedback on proposed changes to publishing information about Good Manufacturing Practice (GMP) compliance on our website.
-
ConsultationHave your say about proposals to amend the Poisons Standard. These will be considered at the next meeting of the Advisory Committee on Medicines Scheduling (ACMS), Advisory Committee on Chemicals Scheduling (ACCS), and the joint meeting of the ACMS and ACCS.
-
DatasetSearch approvals to import and supply medicines not in the Australian Register of Therapeutic Goods (ARTG) to address medicine shortages.
-
PageLearn about the AusUDID and how to use it to meet UDI requirements.
-
PageRead the latest enhancements and fixes to the Australian UDI Database.
-
ChecklistsThese checklists summarise key obligations for psychiatrists applying to prescribe and access MDMA and psilocybine under the Authorised Prescriber scheme.
-
PageClinical resources and guidance on accessing MDMA and psilocybine under the Authorised Prescriber scheme.
-
PageSerious Scarcity Substitution Instruments (SSSIs) allow community pharmacists to substitute specific medicines without prior approval from the prescriber so long as the permitted circumstances within the SSSI are met.
-
PageUnderstand and apply the Unique Device Identification (UDI) requirements to your medical devices.
-
PageUnderstand the AusUDID Pre-Production environment and how you can use it to ensure compliance with the UDI requirements.
-
User guideLearn how to complete an application for consent to import, supply or export medical devices that do not meet UDI-related Essential Principles.
-
GuidanceThis guidance supports psychiatrists in understanding their regulatory requirements when prescribing MDMA and psilocybine from 1 July 2023.
-
Meeting statementsThe Advisory Committee on Medical Devices (ACMD) convened its 89th meeting on 19 February 2026.
-
Meeting statementsThe Advisory Committee on Medical Devices (ACMD) held its 90th meeting on 16 April 2026.
-
PageThe Australian UDI Data Dictionary includes a list of the fields in the database, including element names, descriptions, permitted values and other metadata.
-
PageRead the latest enhancements and fixes to the Australian UDI Database Pre-Production environment.
-
PageThe list of current mesh products supplied in Australia.
-
Scheduling decisions (interim)Interim decisions and invitation for comment. Closing date: 10 July 2026.
-
PageFind out more about the post-market review we are undertaking on plastic syringes.
-
PageResources and technical documents for Machine to Machine (M2M) HL7 SPL users in the Australian Unique Device Identification Database (AusUDID).
-
Safety updatesWe have identified reports of FluMist being administered in error to children under 2 years of age.
-
PageInformation about current processing times, workload, priorities, and key messages for GMP Clearance applications.
-
PageInformation on requesting a pre-submission meeting with the TGA for planned Good Manufacturing Practice (GMP) Licensing, Certification and Clearance applications.
-
PageLinks to information on good manufacturing practice (GMP), manufacturing inspections and manufacturer statutory declarations.